about
In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activityTyrosine kinase 2 - Surveillant of tumours and bona fide oncogene.Methods to study tumor surveillance using tumor cell transplantation into genetically engineered mice.STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion.Conditional ablation of TYK2 in immunity to viral infection and tumor surveillance.NK cell-specific CDK8 deletion enhances antitumor responses.Effect of heme oxygenase-1 on ochratoxin A-induced nephrotoxicity in mice.
P50
Q36107965-5C9DC666-1829-4BC6-8654-73BD5368AC33Q38657462-150E8B2E-A99D-4C9C-ACE7-B62D588B81BEQ38914880-F165C3AB-04D9-4405-BED7-18CEC85375B0Q40912349-CC492F70-CC10-437B-BA9C-D547A3EF242EQ42227306-79C3EAC3-AE11-4EC1-8B99-04F9D582C8AFQ48517843-E69C1AC1-61D2-4E36-9132-76A4642D114AQ51189750-2523F300-F58A-4765-B298-322CFDE2FA8E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Agnieszka Witalisz-Siepracka
@ast
Agnieszka Witalisz-Siepracka
@en
Agnieszka Witalisz-Siepracka
@es
Agnieszka Witalisz-Siepracka
@nl
Agnieszka Witalisz-Siepracka
@sl
type
label
Agnieszka Witalisz-Siepracka
@ast
Agnieszka Witalisz-Siepracka
@en
Agnieszka Witalisz-Siepracka
@es
Agnieszka Witalisz-Siepracka
@nl
Agnieszka Witalisz-Siepracka
@sl
altLabel
Agnieszka Witalisz
@en
prefLabel
Agnieszka Witalisz-Siepracka
@ast
Agnieszka Witalisz-Siepracka
@en
Agnieszka Witalisz-Siepracka
@es
Agnieszka Witalisz-Siepracka
@nl
Agnieszka Witalisz-Siepracka
@sl
P106
P21
P31
P496
0000-0003-0237-0745